1. Home
  2. Analysis
  3. Nebivolol-hydrochloride
  4. Tamsulosin-hydrochloride

Nebivolol hydrochloride and Tamsulosin hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 13 people who take Nebivolol hydrochloride and Tamsulosin hydrochloride. Common interactions include hypotension among males.

The phase IV clinical study analyzes what interactions people who take Nebivolol hydrochloride and Tamsulosin hydrochloride have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

13 people who take Nebivolol hydrochloride and Tamsulosin hydrochloride together, and have interactions are studied.

What is Nebivolol hydrochloride?

Nebivolol hydrochloride has active ingredients of nebivolol hydrochloride. Currently, eHealthMe is studying from 1,697 Nebivolol hydrochloride users.

What is Tamsulosin hydrochloride?

Tamsulosin hydrochloride has active ingredients of tamsulosin hydrochloride. It is used in prostate examination abnormal. Currently, eHealthMe is studying from 15,770 Tamsulosin hydrochloride users.

Number of Nebivolol hydrochloride and Tamsulosin hydrochloride reports submitted per year:

Nebivolol hydrochloride and Tamsulosin hydrochloride drug interactions.

Common Nebivolol Hydrochloride and Tamsulosin Hydrochloride drug interactions by gender *:

female:

n/a

male:

  1. Hypotension
  2. Renal failure acute
  3. Erythema
  4. Fall
  5. Head injury
  6. Hip fracture
  7. Hypercalcaemia
  8. Hypocoagulable state
  9. International normalised ratio increased
  10. Localised oedema

Common Nebivolol Hydrochloride and Tamsulosin Hydrochloride drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Hypotension
  2. Renal failure acute
  3. Erythema
  4. Fall
  5. Head injury
  6. Hip fracture
  7. Hypercalcaemia
  8. Hypocoagulable state
  9. International normalised ratio increased
  10. Localised oedema

Common conditions people have *:

  1. High Blood Pressure: 7 people, 53.85%
  2. High Blood Cholesterol: 3 people, 23.08%
  3. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 23.08%
  4. Type 2 Diabetes: 2 people, 15.38%
  5. Malignant Melanoma (skin cancer rises from melancytes): 2 people, 15.38%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 15.38%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 15.38%
  8. Prostate Cancer: 2 people, 15.38%
  9. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 2 people, 15.38%
  10. Pain: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Nebivolol hydrochloride and Tamsulosin hydrochloride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Nebivolol hydrochloride drug interactions:

Browse interactions between Nebivolol hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tamsulosin hydrochloride drug interactions:

Browse interactions between Tamsulosin hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nebivolol hydrochloride and tamsulosin hydrochloride (the active ingredients of Nebivolol hydrochloride and Tamsulosin hydrochloride, respectively), and Nebivolol hydrochloride and Tamsulosin hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Nebivolol hydrochloride and Tamsulosin hydrochloride.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.